We have developed a novel assisted-circulation apparatus through the integration of nanotechnology, including nano-optical sensor, nano-DLC sensor, nano-control integrated circuit, nano-particle percutaneous energy transfer and nano-actuator. This new device is completely different from the artificial hearts or the ventricular assist devices currently used. Researches have already established the elemental technology, and we are now entering into the integrated experiment phase. Animal experiments have confirmed the cardioassist effect of the new device. According to the timetable, a chronic experiment on the integrated system, with a view to determining the cardioassist effect of the apparatus, and a durability test will be conducted, before we proceed with a preclinical test.